NCT03509220View on ClinicalTrials.gov

Safety and Efficacy of PBK-1701TC for Bowel Cleansing Before Colonoscopy

PHASE3CompletedINTERVENTIONAL
Enrollment

235

Participants

Timeline

Start Date

April 11, 2018

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Colonic DiseasesIntestinal DiseaseGastrointestinal DiseaseDigestive System Disease
Interventions
DRUG

PBK-1701TC

The subject will receive PBK-1701TC for colonoscopy.

DRUG

Standard oral preparation

The subject will receive the standard oral preparation for colonoscopy

Trial Locations (5)

Unknown

Chonnam National University Hospital, Gwangju

Kangbuk Samsung Hospital, Seoul

Korea University Guro Hospital, Seoul

Kyunghee University Hospital, Seoul

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Pharmbio Korea Co., Ltd.

INDUSTRY

NCT03509220 - Safety and Efficacy of PBK-1701TC for Bowel Cleansing Before Colonoscopy | Biotech Hunter | Biotech Hunter